The Nutrition Task Force releases comprehensive recommendations for dementia prevention, emphasizing the critical role of dietary factors in promoting brain health and reducing the risk of cognitive decline among older adults.
Februery 2023
The DECAAF II trial provides one-year follow-up results comparing percutaneous implantation and surgical aortic valve replacement, offering insights into the safety and efficacy of these interventions for aortic valve disease management.
Februery 2023
Improvements in road safety measures have the potential to prevent approximately half a million deaths annually worldwide, with particular benefits for the youngest and poorest populations disproportionately affected by road traffic injuries.
Februery 2023
Guidelines for health examinations in children and adolescents diagnosed with Down syndrome aim to improve the care and management of individuals with this genetic condition, addressing their unique healthcare needs and promoting optimal health outcomes.
Februery 2023
Liver diseases during pregnancy present a diverse spectrum of challenges, ranging from subtle biochemical changes to severe liver failure, underscoring the complexity of their management and the need for tailored approaches to ensure optimal maternal and fetal outcomes.
Februery 2023
Researchers delve into intriguing aspects of famotidine's mechanism of action, particularly its inhibition of adenylate cyclases (ACs), paving the way for the development of novel antibacterial agents targeting this pathway.
Februery 2023
Arterial stiffness shows better predictive capacity for type 2 diabetes risk than hypertension alone, underscoring the potential utility of arterial stiffness measurements in identifying individuals at higher risk of developing diabetes.
Februery 2023
Health authorities gear up to respond to an 'unusual' and widespread outbreak of monkeypox, implementing surveillance, vaccination strategies, and public health interventions to contain the spread of the virus and mitigate its impact.
Februery 2023
The US Preventive Services Task Force (USPSTF) recommends against initiating low-dose aspirin for primary prevention of cardiovascular disease in adults aged 60 years and older, citing insufficient evidence of net benefit and potential harms.
Februery 2023